Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- MedStar Health Awarded an R01 from AHRQ to Apply Artificial Intelligence and Machine Learning to Improve Patient Safety Event Reporting and Analysis
Hyattsville, MD — MedStar Health National Center for Human Factors in Healthcare will be develop... - MedStar Health Awarded Grant to Implement and Evaluate Innovative Sepsis Clinical Decision Support
Through the Diagnostic Quality Improvement Seed Grant Program from the Society to Improve Diagnosis ... - Collaborative Research from MedStar Investigators Evaluate On-Demand Telehealth COVID Screening
A collaborative team of researchers from across MedStar Health recently published research evaluatin...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]